India to Equatorial Guinea Pharmaceutical Export (2026) — $2.5M, 26 Suppliers | TransData Nexus

India to Equatorial Guinea Pharmaceutical Export (2026) — $2.5M, 26 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Equatorial Guinea

#	Formulation	Value	Share
1	Dolutegravir As Sodium Lamivudine Tenofovir Disoproxil Fumarate Tablets 50 300…	$206.7K	8.3%
2	Dolutegravir As Sodium Lamivudine Tenofovir Disoproxil Fumarate Tablets50 300 3…	$132.0K	5.3%
3	Rifampin & Isoniazid Tablets 24x28t Rifampin and Isoniazid Tablets (3750.000 Bo…	$129.8K	5.2%
4	Rifa150+inh75+pzn400+etb275 24x28t Gdf Rifampicinisoniazidpyrazinamide&ethambut…	$125.8K	5.1%
5	Harmless Medicines Artemether 20mg Andlumefantrine 120mg Tablets (lumerax Dt20/…	$113.0K	4.6%
6	Trimethoprim & Sulfamethoxazole 160/800mg (10x10'sx23390 Pack=2339000 Num/table…	$58.1K	2.3%
7	Harmless Medicines Artemether 20mg Andlumefantrine 120mg Tablets (30x18s) ( S P…	$53.5K	2.2%
8	Trimethoprim & Sulfamethoxazole 160/800mg (10x10'sx20000 Pack=2000000 Num/table…	$49.7K	2.0%
9	Harmless Medicines Artemether 20mg Andlumefantrine 120mg Tablets (30x24s) ( S P…	$46.6K	1.9%
10	Harmless Medicines Paracetamol Tabletsbp 500mg (10x10s) ( S Pack) Unit Rate Usd…	$35.7K	1.4%
11	Rifa150+inh75+pzn400+etb275 24x28t Gdf Rifampicin, Isoniazid, Pyrazinamide and…	$29.2K	1.2%
12	Rifampin & Isoniazid Tablets 24x28t Rifampin 150 MG and Isoniazid 75 MG Tablets…	$28.9K	1.2%
13	Sofosbuvir/velpatasvir, Tablets, 400mg/100mg, (400 Packs X 28 )	$22.4K	0.9%
14	Harmless Medicines Larinate-60mg Injection (1x5ml) ( ML Pack) Unit Rate Usd 1.3…	$20.5K	0.8%
15	Rifa150+inh75+pzn400+etb275 24x28tgdf Rifampicin,isoniazid,pyrazinamide and Eth…	$19.4K	0.8%

India exports 17+ pharmaceutical formulations to Equatorial Guinea with a combined trade value of $2.5M. Key products include Isoniazid ($130K), Dolutegravir ($104K), Sodium ($103K), Artemether ($65K), Trimethoprim ($58K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,937 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Equatorial Guinea Trade Routes

1Isoniazid$130K

2Dolutegravir$104K

3Sodium$103K

4Artemether$65K

5Trimethoprim$58K

6Sulfamethoxazole

Top Indian Exporters to Equatorial Guinea

1Sonia Laboratory Private Limited

$771K

2Regal Laboratories

$442K

3Cipla Limited

$373K

4Lupin Limited

$353K

5Ipca Laboratories Limited

Port Analysis — India to Equatorial Guinea Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)20.9%

JNPT5.8%

Bombay Air Cargo3.0%

JNPT/ NHAVA SHEVA SEA3.8%

SAHAR AIR13.5%

Equatorial Guinea Import Ports

MALABO29.8%

Bata33.1%

Malabo12.1%

BATA4.9%

Trade Statistics

Total Value$2.5M

Shipments1,937

Indian Exporters26

Equatorial Guinea Buyers29

Avg Shipment$1K

Products1,637

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Equatorial Guinea Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Equatorial Guinea has experienced steady growth from 2022 to 2026. In 2022, the total export value was $2.5 million USD, with 1,937 shipments from 26 Indian exporters to 29 buyers in Equatorial Guinea. The average shipment value stood at $1,000 USD. By 2024, India's pharmaceutical exports to Equatorial Guinea had increased to $2.21 million USD, indicating a positive growth trajectory. This growth reflects the strengthening trade relations and the expanding presence of Indian pharmaceutical products in the Equatorial Guinean market.

2India's Market Position

India holds a significant position in Equatorial Guinea's pharmaceutical import market. In 2022, India accounted for 9.9% of Equatorial Guinea's total imports, making it one of the key suppliers. This strategic importance is underscored by the consistent demand for Indian pharmaceutical products, driven by their quality and affordability.

3Recent Developments

Between 2024 and 2026, there have been notable developments affecting the India-Equatorial Guinea pharmaceutical trade. In August 2025, Amber Lifesciences Pvt. Ltd., a WHO-GMP and ISO-certified Indian pharmaceutical company, expanded its operations in Equatorial Guinea. The company established partnerships with local distributors and engaged in secondary packaging and labeling, enhancing its market presence. Additionally, in March 2026, the World Health Organization (WHO) updated its health legislation repository, including regulations pertinent to Equatorial Guinea's pharmaceutical sector, which may influence future trade dynamics. (extranet.who.int)

Equatorial Guinea Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Equatorial Guinea must adhere to the guidelines set by the National Drug Regulatory Authority, which follows WHO-GMP standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, detailing product composition, manufacturing processes, and quality control measures. Bioequivalence studies are often required to demonstrate therapeutic equivalence to the reference product. The registration timeline can vary, but companies should anticipate a process spanning several months, depending on the completeness of the submission and regulatory review periods.

2GMP & Facility Requirements

Equatorial Guinea mandates that pharmaceutical products imported into the country be manufactured in facilities compliant with WHO-GMP standards. The inspection process involves a thorough evaluation of manufacturing practices, quality control systems, and facility conditions to ensure adherence to international quality standards. While Equatorial Guinea recognizes WHO-GMP certifications, companies may be subject to additional inspections or documentation requirements to confirm compliance with local regulations.

3Import Documentation

Importing pharmaceutical products into Equatorial Guinea necessitates obtaining an import license from the National Drug Regulatory Authority. Required documentation includes a Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of WHO-GMP compliance. Customs procedures involve submitting these documents along with a commercial invoice, packing list, and bill of lading. It's essential to ensure all documentation is accurate and complete to facilitate smooth customs clearance and avoid potential delays.

TransData Nexus Research · Equatorial Guinea regulatory databasesMar 2026

FAQ — India to Equatorial Guinea Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Equatorial Guinea?

India exported pharmaceuticals worth $2.5M to Equatorial Guinea across 1,937 verified shipments.

Who are the top Indian pharmaceutical exporters to Equatorial Guinea?

1. SONIA LABORATORY PRIVATE LIMITED — $770.6K. 2. REGAL LABORATORIES — $441.5K. 3. CIPLA LIMITED — $372.8K. Total: 26 suppliers.

Which companies in Equatorial Guinea import pharmaceuticals from India?

1. SONIA PHARMACY — $770.6K. 2. PNUD ECUATORIAL GUINEA — $353.9K. 3. NATIONAL TUBERCULOSIS CONTROL — $297.9K. 29 buyers total.

What pharmaceutical products does India export most to Equatorial Guinea?

1. Dolutegravir As Sodium Lamivudine Tenofovir Disoproxil Fumarate Tablets 50 300… ($206.7K, 8.3%); 2. Dolutegravir As Sodium Lamivudine Tenofovir Disoproxil Fumarate Tablets50 300 3… ($132.0K, 5.3%); 3. Rifampin & Isoniazid Tablets 24x28t Rifampin and Isoniazid Tablets (3750.000 Bo… ($129.8K, 5.2%); 4. Rifa150+inh75+pzn400+etb275 24x28t Gdf Rifampicinisoniazidpyrazinamide&ethambut… ($125.8K, 5.1%); 5. Harmless Medicines Artemether 20mg Andlumefantrine 120mg Tablets (lumerax Dt20/… ($113.0K, 4.6%)

Which ports handle pharmaceutical shipments from India to Equatorial Guinea?

Export: NHAVA SHEVA SEA (INNSA1), JNPT, Bombay Air Cargo, JNPT/ NHAVA SHEVA SEA, SAHAR AIR. Import: MALABO, Bata, Malabo, BATA.

Why does Equatorial Guinea import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $2.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Equatorial Guinea?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Equatorial Guinea pharmaceutical trade?

$1.3K per consignment across 1,937 shipments.

How many Indian pharmaceutical companies export to Equatorial Guinea?

26 Indian companies. Largest: SONIA LABORATORY PRIVATE LIMITED with $770.6K.

How can I find verified Indian pharmaceutical suppliers for Equatorial Guinea?

TransData Nexus covers 26 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Equatorial Guinea identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,937 verified shipments from 26 Indian exporters to 29 Equatorial Guinea buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

26 Exporters

29 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Equatorial Guinea Pharmaceutical Export

Top Pharmaceutical Formulations — India to Equatorial Guinea

Top Pharmaceutical Products — India to Equatorial Guinea Trade Routes

Top Indian Exporters to Equatorial Guinea

Port Analysis — India to Equatorial Guinea Pharmaceutical Shipments

Indian Export Ports

Equatorial Guinea Import Ports

Trade Statistics

Other Destinations

India–Equatorial Guinea Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Equatorial Guinea Buyers from India

Product Routes

Full Dataset Access

Equatorial Guinea Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Equatorial Guinea

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Equatorial Guinea

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Equatorial Guinea Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Equatorial Guinea for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Equatorial Guinea

1Competing Origins

2India's Competitive Edge